Journal:
Article Title:
doi:
Figure Lengend Snippet: Bleomycin-induced lung injury reduces endothelial cell populations in the lung. ( A ) Immunoblotting was performed using protein from lung homogenates of C57BL/6 wild-type mice (WT) at Days 0, 1, 3, 7, and 14 after IT bleomycin (0.5 U/kg). Blots were probed for S1PR1, and protein expression levels were compared using GAPDH as a loading control. n = 2–3 mice per group. Densitometry was performed using Image J software (NIH). ( B ) Flow cytometry to identify CD31 + cells was performed on lung tissue from WT mice on Days 0, 7, and 14 after standard-dose IT bleomycin. n = 4 mice per group. ( C ) Flow cytometry of CD31 + cells expressing S1PR1. n = 4 mice per group. ( D ) The percentage of endothelial cells expressing S1PR1 at each time point after bleomycin was quantified. ( E ) Mean fluorescence intensity of S1PR1 in CD31 + cells after bleomycin was quantified. ( F ) Plasma S1P levels in WT mice were quantified at Days 0, 3, 7, 10, and 14 after IT bleomycin. n = 3–4 mice per group. ( G ) Immunoflourescence co-staining on lungs from naive and bleomycin treated mice at Day 14 was performed for S1PR1 (red), endothelial CDH5/VE-cadherin (green), and nuclear DAPI (blue). White box indicates a fibrotic region. Scale bars, 50 μm. * P < 0.05, ** P < 0.01, and *** P < 0.001 for comparisons of cells in WT mice at various time points after bleomycin injury.
Article Snippet: Fibrosis was induced by single-dose intratracheal (IT) injection of bleomycin (Fresenius Kabi) at a standard dose of 1.0 units/kg and also at a reduced dose of 0.5 units/kg, and quantified by measuring hydroxyproline content, per our usual methods ( 20 ).
Techniques: Western Blot, Expressing, Control, Software, Flow Cytometry, Fluorescence, Clinical Proteomics, Staining